IMUNON Enters into Technology Evaluation Agreement with Acuitas Therapeutics to Evaluate IMUNON’s PLACCINE Plasmid DNA with Acuitas’ Lipid Nanoparticle Delivery System
IMUNON Enters into Technology Evaluation Agreement with Acuitas Therapeutics to Evaluate IMUNON’s PLACCINE Plasmid DNA with Acuitas’ Lipid Nanoparticle Delivery System – Nanotechnology News Today – EIN Presswire
Trusted News Since 1995
A service for nanotechnology industry professionals
·
Thursday, November 10, 2022
·
600,574,720
Articles
·
3+ Million Readers
